News & Articles

Company will showcase its new and next-generation products, including Ortho’s VITROS® XT 7600 Integrated System

New Rubella VLPs promise a reliable source of reagents for consistency in immunoassay development and manufacturing

Solutions for automation, assay development, high-throughput screening, imaging and more

Download the microbiome workflow poster from Eppendorf

RAFA 2019 will take place in Prague, Czech Republic, on 5-8 November, 2019

The new system demonstrates bioMérieux’s commitment to automated blood culture - a foundational step to infectious disease diagnosis

AKO MED to exclusively distribute Unyvero A50 portfolio in Serbia, North Macedonia, Bosnia Hercegovina, and Montenegro

Anaerobic workstations from Don Whitley Scientific are being used to develop novel microbial technology for biotherapeutics

Discover the latest technology for the identification of structural variants (SVs) within the human genome

Pioneering microbiome scientist Prof. Patrice Cani reveals how his work has unearthed some of the most groundbreaking discoveries in the world of gut microbes, and how they influence human physiology

Find out how two distinct single-cell RNA-seq approaches were used to create a large-scale Cell Atlas, with this on-demand expert webinar

Reagent-free system identifies microorganisms from isolated colonies with minimal manual work and no sample prep

Next-generation sequencing oligo products to be used in groundbreaking food safety platform

Visitors to earn continuing professional development (CPD) points in the free-to-attend conference programme

Combination of Tecentriq and chemotherapy has demonstrated a significant overall survival (OS) and progression-free survival (PFS) benefit

Akoya Biosciences determines that multiplex immunofluorescence technology preserves critical data missed by other biomarker strategies

New polymers can reduce the amount of organic solvent required in cryopreservation, as well as giving more and healthier cells after thawing

Landmark 15-year study funded by the MS Society has potential to predict the progression of the condition